Try our mobile app

General information

Country: CANADA

Sector: Drug Manufacturers — Specialty and Generic

Categories: @cannabis-players   

Tilray, Inc. operates as a pharmaceutical company. The Company develops cannabis based medicines, drugs, drops, and oil products. Tilray serves clients worldwide.
  • Current market environment: positive. Prices of production are 3.5% higher compared to the last 12 months (LTM)
  • Prices of production are at 30.0% percentile over the past 5 years, adjusted for inflation
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield -5.7% (LTM), projected -8.6%
  • Share price is 1.1% higher than minimum and 87.3% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (-120.0x vs
    )
  • The company is undervalued by EV / projected EBITDA multiple compared to target level (
    vs
    )

Key Financials (Download financials)

Ticker: TLRY
Share price, USD:  (+1.1%)3.61
year average price 7.42  


year start price 16.20 2025-10-04

max close price 21.00 2025-10-09

min close price 3.57 2026-10-01

current price 3.61 2026-10-03
Common stocks: 460 254 275

Dividend Yield:  0.0%
FCF Yield LTM / expected: -5.7% / -8.6%
EV / LTM EBITDA: -120.0x
Production prices change from LTM: 3.5%
EV / projected EBITDA:
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 1 662
Net Debt ($m): 139
EV (Enterprise Value): 1 801
EBITDA LTM ($m): -15
EV / LTM EBITDA: -120.0x
Price to Book: 1.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 75% percentile

Potential dynamics

News


2026-01-30zacks.com

TLRY vs. CGC: Which Cannabis Stock is the Better Investment Now?

2026-01-14zacks.com

What's Next for Tilray Brands After Posting Record Q2 Revenues?

2026-01-13zacks.com

Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings?

2025-12-24fool.com

This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch Next

2025-12-22zacks.com

Tilray Brands, Inc. (TLRY) Stock Falls Amid Market Uptick: What Investors Need to Know

2025-12-22globenewswire.com

Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026

2025-12-18youtube.com

TLRY Soars on Marijuana Reclassification Hopes, Burning Question Centers on Profits

2025-12-15zacks.com

Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today

2025-12-14fool.com

Why Tilray Stock Soared This Week

2025-12-12marketwatch.com

Tilray's stock takes off on hope that cannabis will soon be treated more like steroids than heroin
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company